NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

膽固醇檢驗:體外診斷市場分析及預測模式

Cholesterol Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)

出版商 GlobalData 商品編碼 979402
出版日期 內容資訊 英文
訂單完成後即時交付
價格
膽固醇檢驗:體外診斷市場分析及預測模式 Cholesterol Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
出版日期: 2020年11月30日內容資訊: 英文
簡介

本報告提供全球主要39個國家的膽固醇檢驗的市場調查,彙整市場及產品概要,主要產業趨勢,用戶數(裝置量),新銷售數,平均銷售價格等各種資料及其轉變,產品的年度收益變化與預測,競爭環境與企業佔有率,分析師的各種分析等資料。

主要的調查內容

  • 目前上市的膽固醇檢驗產品·競爭情形
  • 主要的產業趨勢回顧
  • 年度收益的轉變·預測:各種區分
      高密度脂蛋白(HDL)膽固醇實驗室檢驗
    • 低密度脂蛋白(LDL)膽固醇檢驗
    • 整體膽固醇檢驗
    • 多參數膽固醇檢驗
  • 各種詳細資料
    • 用戶數(裝置量)
    • 新銷售數
    • 平均銷售價格等
  • 企業佔有率
  • 分析師分析

本報告書的優點

  • 通過審查管道產品和技術並確定擁有可靠管道的公司,可以建立和設計引入授權和對外授權策略。
  • 通過了解形成並促進產品市場的趨勢,可以訂定業務策略。
  • 通過進一步了解關鍵趨勢,創新產品和技術,有影響力的公司等來提高利潤。
  • 通過了解競爭環境並分析市場領導者的佔有率,可以建立有效的銷售和營銷策略。
  • 確定具有潛在強大產品組合的新興參與者,並製定有效的對策以獲得競爭優勢。
  • 可以追蹤·預測世界·各國設備銷售情況。
  • 通過鎖定能提供最大機會進行合併,投資和戰略合作的市場類別和細分來使銷售/營銷工作系統化。

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME700MM

Cholesterol Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Cholesterol Test market for the year 2020 and beyond. Cholesterol test is performed to identify elevated levels of cholesterol present in the blood. Elevated levels of cholesterol in the blood may increase the risk of heart attack, stroke, and peripheral artery disease. The prevalence of hypertension is one of the largest drivers.

There are a few parameters for the determination of cholesterol in the blood, such as high-density lipoproteins (HDL), low-density lipoproteins (LDL), and total cholesterol. HDL is a marker of "good cholesterol", whereas LDL is known as a marker of "bad cholesterol"; total cholesterol is the overall amount of cholesterol in the blood, including both "good" and "bad" cholesterols. Cholesterol Tests is segmented into High-Density Lipoprotein (HDL) Cholesterol Lab Tests, Low-Density Lipoprotein (LDL) Cholesterol Test, Total Cholesterol Test and Multi-parameter Cholesterol Test.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cholesterol Tests and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Cholesterol Tests market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Cholesterol Tests market.
  • Competitive dynamics insights and trends provided for Cholesterol Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Danaher Corp, Thermo Fisher Scientific Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Cholesterol Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Cholesterol Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Cholesterol Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cholesterol Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Cholesterol Tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.